Quadrant Capital Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-515
| Closed | -$30.3K | – | 2803 |
|
|
2023
Q4 | $30.3K | Buy |
515
+381
| +284% | +$22.4K | ﹤0.01% | 1632 |
|
|
2023
Q3 | $5.84K | Sell |
134
-122
| -48% | -$5.32K | ﹤0.01% | 2134 |
|
|
2023
Q2 | $9.25K | Buy |
256
+180
| +237% | +$6.5K | ﹤0.01% | 2022 |
|
|
2023
Q1 | $2.83K | Sell |
76
-390
| -84% | -$14.5K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $21.1K | Sell |
466
-536
| -53% | -$24.3K | ﹤0.01% | 1634 |
|
|
2022
Q3 | $70K | Buy |
1,002
+301
| +43% | +$21K | 0.01% | 872 |
|
|
2022
Q2 | $47K | Buy |
701
+433
| +162% | +$29K | 0.01% | 901 |
|
|
2022
Q1 | $22K | Buy |
268
+255
| +1,962% | +$20.9K | ﹤0.01% | 1297 |
|
|
2021
Q4 | $2K | Sell |
13
-39
| -75% | -$6K | ﹤0.01% | 2205 |
|
|
2021
Q3 | $9K | Buy |
52
+38
| +271% | +$6.58K | ﹤0.01% | 1671 |
|
|
2021
Q2 | $2K | Sell |
14
-2
| -13% | -$286 | ﹤0.01% | 2179 |
|
|
2021
Q1 | $3K | Sell |
16
-19
| -54% | -$3.56K | ﹤0.01% | 2006 |
|
|
2020
Q4 | $8K | Buy |
+35
| New | +$8K | ﹤0.01% | 1528 |
|
|
2017
Q2 | – | Sell |
-989
| Closed | -$5K | – | 2105 |
|
|
2017
Q1 | $5K | Hold |
989
| – | – | ﹤0.01% | 1353 |
|
|
2016
Q4 | $4K | Buy |
+989
| New | +$4K | ﹤0.01% | 1334 |
|